You just read:

Mallinckrodt's SpecGx LLC Reports on Outcome of FDA Joint Advisory Committee on Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride)

News provided by

Mallinckrodt plc

Nov 14, 2018, 17:08 ET